Candela Introduces High-Powered, Long-Pulsed Dye Laser for Treating Vascular Lesions.WAYLAND, Mass.--(BW HealthWire)--Sept. 9, 1999-- New, Enhanced Version of Company's ScleroPLUS(tm) Hailed as "Treatment of Choice for Hemangiomas and Port-wine Stains" Candela candela (kăndĕ`lə), in weights and measures: see candle. A unit of measurement of the intensity of light. Part of the SI system of measurement, one candela (cd) is the monochromatic radiation of 540THz with a radiant intensity Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CLZR), a leading developer of aesthetic laser systems, recently announced at the American Academy of Dermatology's summer conference the introduction of a new high-powered version of its popular ScleroPLUS laser system. Called the ScleroPLUS-HP(tm), the system has proven highly effective in clinical studies in treating vascular lesions, including hemangiomas and port-wine stains. Generally present at birth, these conditions are caused by an abnormal and acute dilation dilation /di·la·tion/ (di-la´shun) 1. the act of dilating or stretching. 2. dilatation. di·la·tion n. 1. of blood vessels Blood vessels Tubular channels for blood transport, of which there are three principal types: arteries, capillaries, and veins. Only the larger arteries and veins in the body bear distinct names. in the skin that often results in pronounced discoloration dis·col·or·a·tion n. 1. a. The act of discoloring. b. The condition of being discolored. 2. A discolored spot, smudge, or area; a stain. Noun 1. of the epidermis. In the June issue of Skin & Allergy News, a leading publication for dermatologists, Dr. Roy Geronemus of the Laser & Skin Surgery Center of New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of reported on the positive results of a study he conducted in which he treated 50 children and adults with a pre-release version of the ScleroPLUS-HP. He concluded: "This [laser] should be the treatment of choice for untreated or previously treated port-wine stains and superficial to moderately thick hemangiomas." Most impressive, said Geronemus, was the laser's ability to treat infants. Of the 12 treated, 10 had 75 percent or greater clearance after three-and-a-half treatments. No scarring or pigmentary changes were seen. According to Candela, the ScleroPLUS-HP is the only laser on the market today to deliver the combination of high power or fluences - up to 15J/cm2 at 7mm - and dynamic cooling. The system's Dynamic Cooling Device or DCD (Document Content Description) An XML schema language from Textuality, Microsoft and IBM that is implemented as an RDF vocabulary. It supports data typing and schema reuse and is the successor to XML-Data. See XML schema, RDF and XML. (tm) selectively cools the upper layers of skin prior to the laser pulse, minimizing pain and reducing thermal exposure to the epidermis. In addition, the new high-powered "HP" provides the complete range of functionality and features that has long kept Candela's ScleroPLUS in demand by medical professionals. These include the flexibility to select the wavelength - 585, 590, 595, or 600 nm - and the fluence Flu´ence n. 1. Fluency. that is most appropriate for each patient for effective treatment of veins and lesions of different sizes, shapes, locations, and depths. Gerard E. Puorro, Candela's President and Chief Executive Officer, stated: "The ScleroPLUS-HP represents a true advance in laser technology. We expect a strong response to this introduction from both existing and new customers looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. a state-of-the-art system that can deliver improved treatment outcomes for their patients." About Candela Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons and personal care practitioners to treat selected cosmetic and medical conditions using lasers, cryosurgery cryosurgery (krī`ōsr'jərē), bloodless surgical technique using a supercooled probe to destroy diseased or superfluous tissue. and other proven technologies. Founded near Boston in 1970, Candela markets and services its products in over 40 countries from offices in the United States, Europe and Asia. Candela established the aesthetic laser market 11 years ago. With an installed base of over 2,000 lasers worldwide, more than 500,000 aesthetic laser procedures are performed annually with Candela laser systems. For more information about Candela, visit the company's web site at http://www.clzr.com. This press release includes certain forward-looking statements. Any such statements are subject to risks that could cause the actual results to vary materially, including negative developments relating to unforeseen order cancellations or push-outs, Candela's strategic relationships, the impact of intense competition and changes in the laser industry. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion